Form 4 for PTGX Protagonist Therapeutics, Inc
Accepted 2021-08-19 00:00:00 ET · period of report 2021-08-17 · accession 0001104659-21-107818 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-19 | 2021-08-17 | PTGX | Liu David Y | CSO | S - Sale+OE | $47.56 | -14.8K | 58.3K | -20% | -$702.9K |
| D | 2021-08-19 | 2021-08-17 | PTGX | Liu David Y | CSO | M - OptEx | $0.87 | +10.0K | 73.0K | +16% | +$8,700 |
| D | 2021-08-19 | 2021-08-17 | PTGX | Liu David Y | CSO | M - OptEx | $0.00 | -10.0K | 13.8K | -42% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-17 | S | D | 14,779 | $47.56 | 58,254 | D | — | — | (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 7, 2021. (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.10 to $48.34. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. (F1) Includes an aggregate of 606 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on March 9, 2021. |
| 2 | Common | Common Stock | 2021-08-17 | M | A | 10,000 | $0.87 | 73,033 | D | — | — | (F1) Includes an aggregate of 606 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on March 9, 2021. |
| 3 | Derivative | Stock Option (right to buy) | 2021-08-17 | M | D | 10,000 | $0.00 | 13,767 | D | $0.87 · — to 2023-09-26 | 10,000 Common Stock | (F4) The stock option is vested in full. |